Navigation Links
Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device
Date:12/16/2009

(Aarhus, Denmark, December 14, 2009) Unisense FertiliTech A/S has received a further 1.6 million Euro in capital funding to scale up production and support of the EmbryoScope™ Embryo Monitoring System in order to meet the rapidly growing demand for this promising new technology. The capital was invested by LD Pensions and Unisense A/S that continue to own each about 50% of the company.

Aarhus, Denmark (PRWEB) December 16, 2009 -- Unisense FertiliTech A/S has received a further 1.6 million Euro in capital funding to scale up production and support of the EmbryoScope™ Embryo Monitoring System in order to meet the rapidly growing demand for this promising new technology. The capital was invested by LD Pensions and Unisense A/S that continue to own each about 50% of the company.

During IVF treatment, multiple oocytes are removed from the patient and fertilized in-vitro. The resulting fertilized eggs are allowed to develop for a period of 2 to 5 days, before the embryologist must select the best potential embryo or embryos to transfer back to the patient. Ideally, a single embryo resulting in a single pregnancy is optimal as multiple pregnancies present risks to both maternal and fetal health.

A major challenge for the embryologist is determining which embryos have the best potential to create a single healthy baby. The EmbryoScope® Embryo Monitoring System allows uninterrupted time-lapse observation of embryo development in a stable controlled incubation environment. Embryo quality parameters can be assessed and reviewed without the potentially damaging effects of removing the embryo from a stable controlled environment.

CEO Jens Gundersen says they are encouraged with the overwhelming response to the initial sales launch of the instrument, and that with the additional capital, FertiliTech will be able to scale up production to meet the demands of the rapidly expanding interest for the EmbryoScope® Embryo monitoring system.

Unisense FertiliTech A/S is a Danish company which was founded in 2003, as a daughter company of Unisense A/S. The company develops and manufactures instruments and analysis solutions to facilitate in-vitro Fertilization. The company is highly research oriented and is currently involved in various international research projects involving improved embryo selection and analysis, embryo respiration and stem cell research.

Contact Person:
Francesca Bahr
Sales and Marketing Manager
Unisense FertiliTech A/S
Phone Number +45 89449525
Mobile Phone: +45 40255538

Jens K. Gundersen
CEO
+45 21601675

Email Address fab (at) fertilitech (dot) com
Website URL http://www.fertilitech.com

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3339374.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Increased distance to physician associated with thicker skin cancer at diagnosis
2. Methamphetamine study suggests increased risk for HIV transmission
3. New Alzheimers findings: High stress and genetic risk factor lead to increased memory decline
4. Minorities more likely to have sleep durations associated with increased mortality
5. Teens who see more smoking in movies may have increased risk of becoming established smokers
6. Study shows adverse drug events reported to the FDA have significantly increased
7. New Case Study Details How an Illinois Hospital Created a Safe Lifting Team that Dramatically Reduced Injuries, Increased Staff Satisfaction
8. Maternal depression and controlling behavior associated with increased stress response in infants
9. BioProcessors Launches SimCell(TM) Services to Meet Increased Customer Demand
10. Both short and long sleep is associated with increased mortality
11. New Study Shows Lower Costs, Increased Consumer Engagement in Account-Based Health Plans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   ... Spaulding Rehabilitation Network,s Dean Center for Tick ... Physical Medicine and Rehabilitation, MIT Hacking Medicine, University ... for Innovation, today announced the five finalists of ... for Lyme disease.  More than 100 scientists, clinicians, ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
Breaking Medicine Technology: